Abstract In this study, we examined the dynamics of cellular immune responses in the acute phase of dengue virus (DENV) infection in a marmoset model. Here, we found that DENV infection in marmosets greatly induced responses of CD4/CD8 central memory T and NKT cells. Interestingly, the strength of the immune response was greater in animals infected with a dengue fever strain than in those infected with a dengue hemorrhagic fever strain of DENV. In contrast, when animals were re-challenged with the same DENV strain used for primary infection, the neutralizing antibody induced appeared to play a critical role in sterilizing inhibition against viral replication, resulting in strong but delayed responses of CD4/CD8 central memory T and NKT cells. The results in this study may help to better understand the dynamics of cellular and humoral immune responses in the control of DENV infection.
Introduction
Dengue virus (DENV) causes the most prevalent arthropod-borne viral infections in the world [29] . Infection with one of the four serotypes of DENV can lead to dengue fever (DF) and sometimes to fatal dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS) [12] . The serious diseases are more likely to develop after secondary infection with a serotype of DENV that is different from that of the primary infection. Infection with DENV induces a high-titered neutralizing antibody response that can provide long-term immunity to the homologous DENV serotype, while the effect of the antibody on the heterologous serotypes is transient [22] . On the other hand, enhanced pathogenicity after secondary DENV infection appears to be explained by antibody-dependent enhancement (ADE). Mouse and monkey experiments have shown that subneutralizing levels of DENV-specific antibodies actually enhance infection [1, 6, 11] . Thus, the development of an effective tetravalent dengue vaccine is considered to be an important public-health priority. Recently, several DENV vaccine candidates have undergone clinical trials, and most of them target the induction of neutralizing antibodies [20] .
T. Yoshida and T. Omatsu contributed equally to this study. Research of the long-term immune response in humans has provided several interesting parallels to the data. It was reported that complete cross-protective immunity from heterologous challenge was induced in individuals 1-2 months after a primary DENV infection, with partial immunity present up to 9 months, resulting in a milder disease of shorter duration on reinfection, and that complete serotype-specific immunity against symptomatic dengue was observed up to 18 months postinfection [30] . Guzman and Sierra have previously recorded the long-term presence of both DENV-specific antibodies and T cells up to 20 years after natural infections [10, 31] . Of note, increased T cell activation is reportedly associated with severe dengue disease [7, 8] . Thus, the balance between humoral and cellular immunity may be important in the control of dengue diseases.
However, the details regarding the implication of humoral and cellular immunity in controlling DENV infection remain to be elucidated. Previously, passive transfer of either monoclonal or polyclonal antibodies was shown to protect against homologous DENV challenge [13, 15, 16] . It was also reported that neutralizing antibodies played a greater role than cytotoxic T lymphocyte (CTL) responses in heterologous protection against secondary DENV infection in vivo in IFN-a/bR -/-and IFNcR -/-mouse models [18] . Moreover, CD4 ? T cell depletion did not affect the DENV-specific IgG or IgM Ab titers or their neutralizing activity in the IFNcR -/-mouse model [36] . On the other hand, there are several reports showing that cellular immunity rather than humoral immunity plays an important role in the clearance of DENV. For example, in adoptive transfer experiments, although cross-reactive DENV-1-specific CD8
? T cells did not mediate protection against a lethal DENV-2 infection, adoptive transfer of CD4
? T cells alone mediated protection and delayed mortality in IFN-a/bR -/-and IFNcR -/-mouse models [39] . It has also been demonstrated that CD8
? T lymphocytes have a direct role in protection against DENV challenge in the IFN-a/bR -/-mouse model of DENV infection by depleting CD8
? T cells [35] . In addition, previous data from adoptive-transfer experiments in BALB/c mice showed that cross-reactive memory CD8
? T cells were preferentially activated by the secondary DENV infection, resulting in augmented IFN-c and tumor necrosis factor-a (TNF-a) responses, and this effect was serotype-dependent [2, 3] . Although it has previously been suggested that inducing neutralizing antibodies against DENV may play an important role in controlling DENV infection, CTLs are also proposed to contribute to clearance during primary DENV infection and to pathogenesis during secondary heterologous infection in the BALB/c mouse model [4] .
Why did the mouse models of DENV infection show inconsistent results in vivo? One of the reasons could be that these results were obtained mainly from genetically manipulated mice such as IFN-a/bR -/-and IFNcR -/-mice. Moreover, these mice were inoculated with 10 9 -10 10 genome equivalents (GE) of DENV [27, 35, 36] , which were likely in large excess compared with the 10 4 -10 5 GE of DENV injected into humans by a mosquito [19] . In addition, the efficiency of DENV replication in wild mice in vivo is very low compared to that in humans [35] .
Recently, novel non-human primate models of DENV infection using rhesus macaques as well as marmosets and tamarins have been developed [24] [25] [26] 38 ]. An intravenous challenge of rhesus macaques with a high dose of virus inoculum (1 9 10 7 GE) of DENV-2 resulted in readily visible hemorrhaging, which is one of the cardinal symptoms of human DHF [26] . It was also shown that the cellular immune response was activated due to expression of IFN-c, TNF-a, and macrophage inflammatory protein-1 b in CD4
? and CD8 ? T cells during primary DENV infection in rhesus macaques [20] . On the other hand, in the marmoset model of DENV infection, we observed high levels of viremia (10 5 -10 7 GE/ml) after subcutaneous inoculation with 10 4 -10 5 plaque-forming units (PFU) of DENV-2. Moreover, we demonstrated that DENV-specific IgM and IgG were consistently detected and that the DENV-2 genome was not detected in any of these marmosets inoculated with the same DENV-2 strain used in the primary infection [24] . It is notable that while neutralizing antibody titers were at levels of 1:20-1:80 before the rechallenge inoculation, the titers increased up to 1:160-1:640 after the re-challenge inoculation [24] . These results suggested that the secondary infection with DENV-2 induced a protective humoral immunity to DENV-2 and that DENV-infected marmoset models may be useful in order to analyze the relationship between DENV replication and the dynamics of adaptive immune responses in vivo.
Taking these findings into consideration, we investigated the dynamics of cellular immunity in response to primary and secondary DENV infection in the marmoset model.
Materials and methods

Animals
All animal studies were conducted in accordance with protocols of experimental procedures that were approved by the Animal Welfare and Animal Care Committee of the National Institute of Infectious Diseases, Japan, and the National Institute of Biomedical Innovation, Japan. A total of six male marmosets, weighing 258-512 g, were used. Common marmosets were purchased from Clea Japan Inc.
(Tokyo, Japan) and caged singly at 27 ± 2°C in 50 ± 10 % humidity with a 12-h light-dark cycle (lighting from 7:00 to 19:00) at Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Tsukuba, Japan. Animals were fed twice a day with a standard marmoset diet (CMS-1M, CLEA Japan) supplemented with fruit, eggs and milk. Water was given ad libitum. The animals were in healthy condition and confirmed to be negative for anti-dengue-virus antibodies before inoculation with dengue virus [24] .
Cells
Cell culture was performed as described previously [24] . Vero cells were cultured in minimum essential medium (MEM, Sigma) with 10 % heat-inactivated fetal bovine serum (FBS, GIBCO) and 1 % non-essential amino acid (NEAA, Sigma) at 37°C in 5 % CO 2 . C6/36 cells were cultured in MEM with 10 % FBS and 1 % NEAA at 28°C in 5 % CO 2 . centrifuged at 3,000 rpm for 5 min to remove cell debris and then stored at -80°C until use.
Infection of the marmosets with DENV
In the challenge experiments, profiling of the key adaptive and innate immune cells in the marmosets after infection with DENV-2 was done. For primary DENV infection, four marmosets were inoculated subcutaneously in the back with either 1.9 9 10 5 PFU of the DENV-2 Mal/77/08 strain (Cj08-007, Cj07-011) or 1. 8 9 10 4 PFU of the DHF0663 strain (Cj07-006, Cj07-008) [24] . In the case of the DENV re-challenge experiment, two marmosets initially inoculated with 1.8 9 10
5 PFU of the DHF0663 strain were re-inoculated 33 weeks after the primary challenge with 1.8 9 10
5 PFU of the same strain (Cj07-007, Cj07-014) [24] . Blood samples were collected on days 0, 1, 3, 7, 14, and 21 after inoculation and were used for virus titration and flow cytometric analysis. Inoculation with DENV and blood drawing were performed under anesthesia with 5 mg/kg of ketamine hydrochloride. Day 0 was defined as the day of virus inoculation. The viral loads in marmosets obtained in a previous study are shown in Supplementary Figure 1 [24] .
Flow cytometry
Flow cytometry was performed as described previously [37] . Fifty microliters of whole blood from marmosets was stained with combinations of fluorescence-conjugated monoclonal antibodies; anti-CD3 (SP34-2; Becton Dickinson), anti-CD4 (L200; BD Pharmingen), anti-CD8 (CLB-T8/4H8; Sanquin), anti-CD16 (3G8; BD Pharmingen), anti-CD95 (DX2; BD Pharmingen), and anti-CD62L (145/ 15; Miltenyi Biotec). Then, erythrocytes were lysed with FACS lysing solution (Becton Dickinson). After washing with a sample buffer containing phosphate-buffered saline (PBS) and 1 % FBS, the labeled cells were resuspended in a fix buffer containing PBS and 1 % formaldehyde. The expression of these markers on the lymphocytes was analyzed using a FACSCanto II flow cytometer (Becton Dickinson). The data analysis was conducted using FlowJo software (Treestar, Inc.). Results are shown as mean ± standard deviation (SD) for the marmosets used in this study.
Results
Naïve central/effector memory T cells and NK/NKT cells in marmosets
Basic information regarding CD4/CD8 naïve and central/ effector memory T cells and NK/NKT cells in common marmosets was unavailable. Thus, we examined the immunophenotypes of lymphocyte subsets in the marmosets (Fig. 1) . The gating strategy for profiling the CD4 and CD8 T cells in the marmosets by FACS is shown in Fig. 1a T lymphocytes in the total lymphocytes of three marmosets was found to be 75.7 ± 6.4 %. The average ratio of CD4
? T cells in the CD3
? subset was 65.4 ± 6.8 %. The average ratios of CD4 ? T N , T CM , and T EM cells were 65.9 ± 3.7 %, 16.4 ± 2.9 %, 19.5 ± 2.5 %, respectively. The average ratio of CD8
? T cells in the CD3 ? subset was 29.0 ± 8.0 %. The average ratios of CD8 ? T N , T CM , and T EM cells were 66.7 ± 10.2 %, 4.7 ± 3.6 %, 28.8 ± 14.8 %, respectively.
We recently characterized a CD16 ? major NK cell subset in tamarins and compared NK activity in tamarins with or without DENV infection [37, 38] . In terms of NKT cells, NK1.1 (CD161) and CD1d are generally used as markers of NKT cells [32] . However, these anti-human NK1.1 and CD1d antibodies are unlikely to cross-react with the NKT cells of the marmosets. Thus, we defined NKT cells as a population expressing both CD3 and CD16 as reported previously [14, 17] . The NK and NKT cell subsets were determined to be CD3 -CD16 ? and CD3
? CD16 ? lymphocytes in the marmosets. The average ratios of NK and NKT cell subsets in the lymphocytes were 4.2 ± 2.6 % and 5.1 ± 3.4 %, respectively (Table 1) . We observed that the proportions of the major lymphocyte Results shown are mean ± SD from 3 healthy marmosets subsets in the marmosets were similar to those in cynomolgus monkeys and tamarins [37, 38] .
Profiling of CD4 and CD8 T, NK and NKT cells in marmosets after primary infection with DENV-2 (Mal/77/08 strain)
We investigated the cellular immune responses against DENV-2 DF strain (Mal/77/08) in marmosets. Dengue vRNA was detected in plasma samples from two marmosets on day 2 postinfection (Supplementary Fig. 1a ). For the two marmosets (Cj08-007, Cj07-011), the plasma levels of vRNA reached their peaks at 9.6 9 10 6 and 7.0 9 10 6 GE/ml, respectively, on day 4 postinfection. Plasma vRNA was detected in both marmosets on days 2, 4, and 7. We then examined the profiles and frequencies of the CD4 and CD8 T, NK and NKT cells in the infected marmosets (Figs. 2-3 and Table 2 ). CD4 ? T CM cells drastically increased to 88.7 ± 2.8 % from 13 ± 0.4 % between day 0 and day 2 post-inoculation (Table 2) . Reciprocally,
CD4
? T N cells decreased to 1.6 ± 3.3 % from 74.1 ± 0.9 % at the same time. CD4
? T EM cells maintained the initial levels throughout the observation period. CD8
? T CM cells increased to 91.9 ± 5.5 % from 2.1 ± 0.8 % between day 0 day 2 post-inoculation, and reciprocally, CD8
? T N cells decreased to 2.5 ± 4.7 % from 89.9 ± 2.5 % at the same time. In addition, NK cells maintained their initial levels throughout the observation period. However, NKT cells drastically increased to 52.6 ± 17 % from 0.2 ± 0.0 % between day 0 and day 2 post-inoculation. These results suggest that CD4/CD8 T and NKT cells may efficiently respond to the Mal/77/08 strain of DENV.
Profiling of CD4 and CD8 T, NK and NKT cells in the marmosets after primary infection with DENV-2 (DHF0663 strain) Next, we investigated cellular immune responses against another DENV-2 DHF strain (DHF0663) in marmosets. Dengue vRNA was detected in plasma samples from the marmosets on day 2 post-infection ( [24] , Supplementary  Fig. 1b) . For the two marmosets (Cj07-006, Cj07-008), the plasma vRNA levels were found to be 3.4 9 10 5 and 3.8 9 10
5 GE/ml on day 2 and 2.0 9 10 6 and 9.4 9 10 5 GE/ml, respectively, at the peak on day 4 post-infection and became undetectable by day 14. Thus, we examined the profiles and frequencies of the CD4 ? and CD8 ? T, NK and NKT cells in these DENV-infected marmosets (Fig. 4-5 and Table 3 ). It was found that on day 7 postinoculation, CD4
? and CD8 ? T N cells decreased, and in contrast, the T CM populations increased in both marmosets; however, the changes in proportion were much less pronounced than in the case of the marmosets infected with the DF strain. We observed no consistent tendency in the kinetics of CD4
? and CD8 ? T EM cells nor in NK and NKT cells. These results suggest that the strength of T cell responses may be dependent on the strain of DENV.
Profiling of CD4 and CD8 T, NK and NKT cells in marmosets re-challenged with a DENV-2 strain In order to examine the cellular immune responses against re-challenge with a DENV-2 DHF strain in the marmoset model, marmosets were infected twice with the same DENV-2 strain (DHF0663) with an interval of 33 weeks after the primary infection. The results showed that vRNA and NS1 antigens were not detected in plasma and that the neutralizing antibody titer was obviously increased after the secondary infection. The data indicated that the primary infection induced protective immunity, including a neutralizing antibody response to re-challenge with the same DENV strain ( [24] ; Supplementary Fig. 1c) . We also investigated the profiles of the CD4 and CD8 T, NK and NKT cells in the marmosets (Cj07-007, Cj07-014) that were re-challenged with the same DENV-2 strain (DHF0663) (Figs. 6-7 ). CD4
? T CM cells drastically increased on day 14 post-inoculation. On the other hand, (NKT) 7.8 ± 1.0 9.3 ± 4.5 5.9 ± 2.6 22.6 ± 8. 
Days post inoculation
CD4
? T N cells decreased strongly at the same time. CD4
? T EM cells maintained their initial levels through the observation period. Similarly, CD8 ? T CM and NKT cells clearly increased on day 14 post-inoculation. Importantly, these T cell responses were induced one week after the obvious induction of the neutralizing antibody in the marmosets [24] . These results suggest that the neutralizing antibody may play a critical role in the complete inhibition of the secondary DENV infection.
Discussion
In this study, we demonstrated the dynamics of the central/ effector memory T cells and NK/NKT subsets against DENV infection in our marmoset model. First, we characterized the central/effector memory T and NK/NKT subsets in marmosets (Fig. 1) . Second, we found that CD4/ CD8 central memory T cells and NKT cells had significant responses in the primary DENV infection, and the levels appeared to be dependent on the strain of the virus employed for challenge experiments (Figs. 2-5 ). Finally, we found delayed responses of CD4/CD8 central memory T cells in the monkeys re-challenged with the same DENV DHF strain, despite the complete inhibition of DENV replication (Figs. 6-7) .
The present study shed light on the dynamics of cellular and humoral immune responses against DENV in vivo in the marmoset model. Our results showed that cellular immune responses were induced earlier than antibody responses in the primary infection. Thus, our results suggest the possibility that cellular immunity may contribute, at least in part, to the control of primary DENV infection. On the other hand, in the presence of neutralizing antibodies in the re-challenged monkeys [24] , delayed (on day 14 after the re-challenge) responses of CD4/CD8 central memory T cells were observed despite the complete inhibition of DENV replication. These results indicate that cellular immunity is unlikely to play a major role in the control of DENV re-infection. Alternatively, it is still possible that components of cellular immunity, such as memory T cells, could partially play a helper role for the enhanced induction of neutralizing antibodies even without an apparent increase in the proportion of T CM , resulting in efficient prevention of DENV replication.
It is possible that the DENV strains used in this study influence the strength of cellular immune responses. The differences in cellular immune responses between the monkeys infected with the DF and DHF strains are probably not caused by individual differences in the marmosets, because the FACS results were consistent with each pair of marmosets. It was shown previously that there was a reduction in CD3, CD4, and CD8 cells in DHF and that lower levels of CD3, CD4, and CD8 cells discriminated DHF from DF patients during the febrile stage of illness [5] . There was a significant increase in an early activation marker on CD8
? T cells in children with DHF compared with DF during the febrile period of illness [8] . Another group reported that levels of peripheral blood mononuclear cell apoptosis were higher in children developing DHF [23] . Moreover, cDNA array and ELISA screening demonstrated that IFN-inducible genes, IFN-induced genes and IFN production were strongly up-regulated in DF patients when compared to DHF patients, suggesting a significant role of the IFN system during infection with DF strains when compared to DHF strains [34] . Thus, it is reasonable to assume that DHF strains might have the ability to negatively regulate T cell responses. A recent report demonstrating that the sequence of a DHF strain differed from that of a DF strain at six unique amino acid residues located in the membrane, envelope and non-structural genes [33] , which supports our notion.
Alternatively, another possibility is that the strength of T cell responses might depend on the viral load. In fact, in our results, the stronger T cell responses in monkeys infected with the DF strain were paralleled by higher viral loads, which was in contrast to the result obtained with DHF-strain-infected animals with lower viral loads. Of note, the tenfold higher challenge dose of the DF strain used in this study (1.9 9 10 5 PFU) compared to the DHF strain (1.8 9 10
4 PFU) could have simply led to tenfold higher peak viral RNA levels in monkeys infected with the DF strain. In either case, the relationship between the strength of the antiviral immune response and the viral strain remains to be elucidated. Further in vivo characterization of the antiviral immunity and the viral replication kinetics induced by infection with various DENV strains isolated from DF and DHF patients will help to understand the mechanism of differential disease progression in the course of DENV infection.
We observed that dengue vRNA was not detected in plasma samples from marmosets re-infected with the same DENV-2 DHF strain 33 weeks after the primary infection. This result suggests that memory B cells induced in the primary DENV infection were predominantly activated to produce neutralizing antibodies against the same DHF strain in the secondary infection in the absence of apparent cellular immune responses. A previous report showed that DENV infection induces a high-titered neutralizing antibody that can provide long-term immunity to the homologous DENV serotype [22] , which is consistent with our results. By contrast, the role of cellular immune responses in the control of DENV infection remains to be elucidated. Our results in this study may suggest that cellular immune responses and neutralizing antibodies acted cooperatively to control primary DENV infection. In DENV-infected patients, it may be difficult to distinguish whether each case is primary or secondary DENV infection and also to serially collect blood samples for immunological study in the course of the infection, which is likely to be the reason for the discrepancy regarding the importance of cellular immunity in DENV infection. From this point of view, our marmoset model of DENV infection will further provide important information regarding the role of cellular immune responses in DENV infection.
